Anaida Nadal Torres
Rheumatology · Guayama, PRNPI 1598868531
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. E.r. Squibb & Sons, L.L.C. accounts for 63.9% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2020 at $4,052 and has fallen 78.1% since, to $887 in 2025.
Across 271 payments — averaging $58.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$10K
- AbbVie$1K
- Novartis$1K
- Amgen$966
- AstraZeneca$528
- GSK$408
- plus $1K from 14 others
What the payments were for
- Consulting fees$5,22533%
- Speaking & faculty fees$4,82830%
- Food & beverage$5,63335%
- Education$1981%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 56 | $10,156 |
| AbbVie | 45 | $1,385 |
| Novartis | 60 | $1,065 |
| Amgen | 38 | $966 |
| AstraZeneca | 23 | $528 |
| GSK | 16 | $408 |
| Bristol Myers Squibb | 1 | $300 |
| Mallinckrodt Hospital Products Inc. | 2 | $198 |
| Eli Lilly Export S.A. Puerto Rico Branch | 5 | $193 |
| Johnson & Johnson | 7 | $192 |
| Lilly USA, LLC | 1 | $113 |
| PBG Puerto Rico LLC | 5 | $83 |
| Pfizer | 1 | $79 |
| Boehringer Ingelheim | 2 | $51 |
| UCB, Inc. | 2 | $41 |
| Sanofi | 2 | $38 |
| Organon | 1 | $25 |
| Radius Health, Inc. | 2 | $24 |
| Pfizer Pharmaceuticals LLC | 1 | $20 |
| Merck | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,884 in reported general payments places this provider in the 85th percentile of 88 rheumatology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 319 | $2,191,457 |
| Orencia ClickjectAbatacept | 232 | $1,315,011 |
| RinvoqUpadacitinib | 198 | $1,279,154 |
| Enbrel SureclickEtanercept | 101 | $757,283 |
| Xeljanz XrTofacitinib Citrate | 95 | $550,116 |
| Skyrizi PenRisankizumab-Rzaa | 18 | $375,148 |
| KevzaraSarilumab | 79 | $344,055 |
| Cosentyx Sensoready PenSecukinumab | 40 | $296,992 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 29 | $210,599 |
| BenlystaBelimumab | 42 | $194,862 |
| Taltz AutoinjectorIxekizumab | 26 | $187,633 |
| Humira(Cf)Adalimumab | 25 | $170,990 |
| SimponiGolimumab | 27 | $162,301 |
| ProliaDenosumab | 84 | $148,916 |
| Actemra ActpenTocilizumab | 40 | $94,207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Humira(Cf) | $1,385 | $1,450,144223 claims |
| SanofiKevzara | $38 | $344,05579 claims |
| GSKBenlysta | $408 | $194,86242 claims |
| Johnson & JohnsonSimponi | $192 | $162,30127 claims |
| AmgenProlia | $966 | $148,91684 claims |
| E.r. Squibb & Sons, L.L.C.Orencia | $10,156 | $85,99315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 88 rheumatology providers in Puerto Rico.
Other rheumatology in Guayama
- Radames Sierra ZoritaSan Juan$428K
- Oscar Soto RaicesSan Juan$352K
- Yvonne FontSan Juan$193K
- Paloma AlejandroSan Juan$33K
- Linnette Lopez LopezArecibo$28K
- Jose Rodriguez SantiagoSanturce$26K
- Roberto Alvarez SwihartAibonito$20K
- Amarilis Perez de JesusCaguas$18K
- Roberto Leon-PerezPonce$17K
- Sonialy Lugo RuizAguadilla$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.